About
Overview
Management team
Board of directors
Investors
Scientific advisory board
Innovation
Overview
Pipeline
Technology
Clinical trials
Overview
LUCE-1
STELLA
CELESTE
For patients
Overview
Usher 1B
Stargardt
Expanded access
News
Careers
Overview
Corporate values
Recruitment companies
Contact
EN
English
Italiano
Search
News
News
Filter by:
All categories
All categories
Press Release
Publication
All disease areas
All disease areas
Stargardt
Usher 1B
Other
By year:
All years
All years
2025
2024
2023
2022
2021
2019
2014
Reset
24.04.2024
Press Release
Stargardt
AAVantgarde announces updated NHP data for its Stargardt program to be presented at ARVO 2024
23.04.2024
Press Release
Stargardt
AAVantgarde presents large animal models preclinical data at ASGCT 2024
31.01.2024
Press Release
Other
AAVantgarde appoints Nina (Ekaterini) Kotsopoulou, Ph.D., as Chief Technical Officer
08.11.2023
Press Release
Other
AAVantgarde Appoints Dr. Peter K. Kaiser to the Board of Directors
30.10.2023
Press Release
Other
AAVantgarde Appoints Michael Heffernan as Chairman of its Board of Directors
12.09.2023
Press Release
Other
AAVantgarde Appoints Dr. Doug Kerr to the Board of Directors
06.06.2023
Press Release
Other
AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic
08.09.2022
Press Release
Other
AAVantgarde Bio appoints Dr. Natalia Misciattelli as Chief Executive Officer
30.06.2022
Press Release
Other
AAVantgarde announces the appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
30.03.2022
Press Release
Other
AAVantgarde appoints Ram Palanki as Chairman of its Board of Directors
30.06.2021
Press Release
Sofinnova Partners announces three new investments from its fund dedicated to Italian scientific research